CDDP is named as a drug or biological intervention in 5 clinical trials in our Ireland and China trial registers, 3 of which are recruiting. Lead sponsors include Centre Leon Berard (1), University of Birmingham (1) and Alliance for Clinical Trials in Oncology (1). Registered phases: Phase 3, Phase 2 and Phase 2/3. Conditions studied include Childhood Ependymoma; Oropharyngeal Cancer; Germ Cell Tumor.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT02265770 | An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma Childhood Ependymoma |
Phase 2/3 | Recruiting |
| NCT06055738 | Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC (ClinicalTrials.gov ↗) Locally Advanced Cervical Cancer |
Phase 2 | Recruiting |
| NCT06091124 | Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma (ClinicalTrials.gov ↗) Neuroendocrine Carcinoma of the Bladder, Bladder Cancer |
Phase 2 | Recruiting |
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (ClinicalTrials.gov ↗) Germ Cell Tumor, Teratoma, Choriocarcinoma |
Phase 3 | Active, closed |
| NCT04116047 | CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) (ClinicalTrials.gov ↗) Oropharyngeal Cancer |
Phase 3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Childhood Ependymoma | 1 |
| Oropharyngeal Cancer | 1 |
| Germ Cell Tumor | 1 |
| Teratoma | 1 |
| Choriocarcinoma | 1 |
| Germinoma | 1 |
| Neuroendocrine Carcinoma of the Bladder | 1 |
| Bladder Cancer | 1 |
| Locally Advanced Cervical Cancer | 1 |
| Lead sponsor | Trials |
|---|---|
| Centre Leon Berard | 1 |
| University of Birmingham | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| RenJi Hospital | 1 |
| Tang-Du Hospital | 1 |
| Register | CDDP trials |
|---|---|
| Clinical trials in Ireland | 3 |
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how CDDP works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists CDDP (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.